Literature DB >> 23589165

Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1) through modulation of the MAPK/ERK pathway.

Ke-Kang Sun1, Ning Zhong, Yang Yang, Lin Zhao, Yang Jiao.   

Abstract

Transducer of erbB2.1 (TOB1) is a member of the B-cell translocation gene (BTG)/transducer of erbB2 (TOB) anti‑proliferative protein family. Previous studies have demonstrated that overexpression of TOB1 significantly enhances the radiosensitivity of breast and cervical cancer cells. However, the potential mechanisms of TOB1 are still debated. In the present study, we evaluated the effects of infrared (IR) radiation on TOB1 expression in the human lung cancer cell lines NCI-H1975 and A549 via western blot analysis. NCI-H1975 cells were transfected with TOB1 recombinant plasmid, and A549 cells were treated with TOB1-small interfering RNA (siRNA) to establish gain-of-function and loss-of‑function cell models. The effects of radiation and TOB1 overexpression and silencing on clonogenic survival, cell cycle distribution and DNA repair were assessed. Western blot analysis was performed to determine the related mechanisms. The expression levels of TOB1 were significantly induced by IR radiation. Overexpression of TOB1 abrogated radiation-induced G2/M arrest, reduced clonogenic cell survival and enhanced γ-H2AX foci in NCI-H1975 cells exposed to irradiation. TOB1-siRNA demonstrated opposite effects in A549 cells. TOB1 regulated the activation of mitogen-activated protein kinase (MAPK) and modulated the phosphorylation of p53 via activation of the MAPK/extracellular signal-regulated kinase (ERK) pathway. The findings suggest that TOB1 may be a novel molecular target of irradiation. TOB1 modulated the radiosensitivity of lung cancer cells via the MAPK/ERK signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589165     DOI: 10.3892/or.2013.2403

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients.

Authors:  Yaoyao Dai; Zuxiong Tang; Zongguo Yang; Lan Zhang; Qing Deng; Xiaofeng Zhang; Yongchun Yu; Xing Liu; Junfeng Zhu
Journal:  Cell Cycle       Date:  2018-10-20       Impact factor: 4.534

2.  miRNA-32 Drives Brown Fat Thermogenesis and Trans-activates Subcutaneous White Fat Browning in Mice.

Authors:  Raymond Ng; Nurul Attiqah Hussain; Qiongyi Zhang; Chengwei Chang; Hongyu Li; Yanyun Fu; Lei Cao; Weiping Han; Walter Stunkel; Feng Xu
Journal:  Cell Rep       Date:  2017-05-09       Impact factor: 9.423

3.  A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy.

Authors:  Wanzun Lin; Zongwei Huang; Yanyan Xu; Xiaochuan Chen; Ting Chen; Yuling Ye; Jianming Ding; Zhangjie Chen; Long Chen; Xianxin Qiu; Sufang Qiu
Journal:  Aging (Albany NY)       Date:  2020-05-26       Impact factor: 5.682

4.  TOB1-AS1 suppresses non-small cell lung cancer cell migration and invasion through a ceRNA network.

Authors:  Wen-Ji Shangguan; Hai-Tao Liu; Zu-Jun Que; Fang-Fang Qian; Ling-Shuang Liu; Jian-Hui Tian
Journal:  Exp Ther Med       Date:  2019-10-15       Impact factor: 2.447

5.  MiR-32-5p Regulates Radiosensitization, Migration And Invasion Of Colorectal Cancer Cells By Targeting TOB1 Gene.

Authors:  Hong Liang; Yumei Tang; Hui Zhang; Chao Zhang
Journal:  Onco Targets Ther       Date:  2019-11-14       Impact factor: 4.147

Review 6.  Magic and mystery of microRNA-32.

Authors:  Z L Zeng; Qingyun Zhu; Zhibo Zhao; Xuyu Zu; Jianghua Liu
Journal:  J Cell Mol Med       Date:  2021-08-18       Impact factor: 5.310

7.  Effect of Epigallocatechin-3-Gallate on EGFR Signaling and Migration in Non-Small Cell Lung Cancer.

Authors:  Cristina Minnelli; Laura Cianfruglia; Emiliano Laudadio; Giovanna Mobbili; Roberta Galeazzi; Tatiana Armeni
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

8.  Luminescent ruthenium(II) polypyridyl complexes acted as radiosensitizer for pancreatic cancer by enhancing radiation-induced DNA damage.

Authors:  Yuyang Zhou; Ying Xu; Lunjie Lu; Jingyang Ni; Jihua Nie; Jianping Cao; Yang Jiao; Qi Zhang
Journal:  Theranostics       Date:  2019-09-18       Impact factor: 11.556

9.  TOB1 suppresses proliferation in K-Ras wild-type pancreatic cancer.

Authors:  Yuru Bai; Lu Qiao; Ning Xie; Yan Li; Yongzhan Nie; Yan Pan; Yupeng Shi; Jinhai Wang; Na Liu
Journal:  Cancer Med       Date:  2019-12-31       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.